Person named in the records

James Niedel

Named in 2 passages across 2 documents.

Mentions of James Niedel in the public Epstein records, with citations.

Ask the documents about James Niedel Search every mention

--}}

Being named in these documents is not an accusation or evidence of wrongdoing. This page reflects only what the public records literally contain, with citations to the original sources.

Where James Niedel appears

2 total

Clinical Pharmacology and Principal Investigator on studies of mechanisms of cancer and inflammation at Duke Medical School, where he had completed an Internal Medicine residency and a Hematology-Medical Oncology fellowship. Jim received hi...

Times Square Tower TEXT-001-HOUSE_OVERSIGHT_024003.txt p.1 View source release ↗

James Niedel, MD, Ph.D., (70), Venture Partner, joined Sprout in May 2002 and helped found New Leaf in 2005. Jim will change his status to Venture Partner in NLV-II] with the closing of the new fund. In this role, Jim will work full-time as...

James Niedel, MD, Ph.D., (70), Venture Partner, joined Sprout in May 2002 and helped found IMAGES-007-HOUSE_OVERSIGHT_024024.txt p.1 View source release ↗

Also named alongside

New York New Leaf NEW LEAF VENTURES III, L.P Harvard Medical School U.S. Securities and Exchange Commission NEW LEAF VENTURE PARTNERS, L.L.C Boston Consulting Group New Leaf Ventures I, L.P All Sprout Funds U.S. Congress New Leaf Venture Partners Philippe Chambon

Want context across all of these passages at once?

Ask the documents about James Niedel